Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Connective and Soft Tissue » Neoplasms, Connective Tissue » Neoplasms, Bone Tissue » Osteosarcoma » Sarcoma, Ewing
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Connective and Soft Tissue » Sarcoma » Osteosarcoma » Sarcoma, Ewing
Description
A malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. The tumor occurs usually before the age of 20, about twice as frequently in males as in females. MeSH
Hierarchy View
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (1)
Phase 3 Indicated Drugs (17)
Phase 1 Indicated Drugs (33)
Other Experimental Indicated Drugs (7)
Organization Involved with Phase 3 Indications (12)
Organization Involved with Phase 2 Indications (85)
ChemoWarrior: the eli sidler foundation
Children's Cancer and Leukaemia Group
City of Hope National Medical Center
Grupo Espanol de Investigacion en Sarcomas
Hospital Universitario Niño Jesús
Istituto Clinico Humanitas - Rozzano (MI), Italy
KK Women's and Children's Hospital
National Institutes of Health (NIH)
National Pediatric Cancer Foundation
National University of Singapore
Neuroblastoma and Medulloblastoma Translational Research Consortium
Sarcoma Alliance for Research through Collaboration
Sarcoma Oncology Research Center, LLC
Shenzhen Geno-Immune Medical Institute
Organization Involved with Phase 1 Indications (36)
Organization Involved with Other Experimental Indications (7)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.